Ribosomal Protein S19 Antibodies

Santa Cruz Biotechnology delivers a wide array of Ribosomal Protein S19 monoclonal antibodies for research in understanding cellular function. Ribosomal Protein S19 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Ribosomal Protein S19 is an essential component of the ribosome, playing a pivotal role in protein synthesis and cellular growth. The protein is involved in the assembly of ribosomal subunits and is crucial for maintaining the structural integrity of the ribosome. Research has shown that Ribosomal Protein S19 dysfunction can lead to various diseases, including cancer. Scientists can utilize Ribosomal Protein S19 monoclonal antibodies to investigate protein expression patterns, localization, and interactions within cellular pathways. Understanding Ribosomal Protein S19's role in disease progression may reveal new therapeutic targets and treatment strategies. Ongoing studies with Ribosomal Protein S19 monoclonal antibodies continue to uncover important insights about ribosomal biology and disease mechanisms. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of ribosomal biology and its implications in health and disease.